Multiple myeloma trials in South Korea

2 of 35 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

  Where

  Hwasun, Seoul

  Age

  18 years and over

  People

  15

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT06698887
• No phaseTaking people
  Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies

  Where

  Seocho

  Age

  19 years and over

  People

  174

  Run by

  Sung-Soo Park

  See details and how to joinNCT07051850